Other predicted mechanisms include JAK/STAT3-mediated production of IL-10 and TGFβ [133], promotion of switching from M1 to M2 macrophages [134], and suppression of anti-tumor immunity via the CCL2-CCR2-M2 macrophage axis [135]. The gene discussed is TGFB1; the disease is neoplasm.